A review of the clinical evidence related to early treatment of elevated LDL for cardiovascular primary prevention

Evid Based Med. 2015 Oct;20(5):162-9. doi: 10.1136/ebmed-2015-110170. Epub 2015 Jul 14.

Authors

Kori Sauser¹, Deborah A Levine², Rodney A Hayward²

Affiliations

¹ Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
² Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA Center for Clinical Management Research, Ann Arbor Veterans Affairs Hospital, Ann Arbor, Michigan, USA.

PMID: 26173413
DOI: 10.1136/ebmed-2015-110170

No abstract available

Keywords: CARDIOLOGY.

Publication types

Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Review

MeSH terms

Cardiovascular Diseases / prevention & control*
Cholesterol, LDL / blood*
Evidence-Based Medicine*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hyperlipidemias / drug therapy*
Primary Prevention*

Substances

Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Grants and funding